RxDoctor Payments Data

Kaleah Hendren, NP

Family · Harmony, NCNPI 1518525484

Payments from drug & device makers

$449in general payments, 2019–2025

Across 27 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$96
  • Exact Sciences$87
  • AstraZeneca$76
  • Novo Nordisk$62
  • GSK$42
  • Boehringer Ingelheim$38
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$449100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$449 in reported general payments places this provider in the 55th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,008
Medicare patients
43
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$77,290
MounjaroTirzepatide66$68,818
EliquisApixaban90$63,714
JanuviaSitagliptin Phosphate57$44,683
JardianceEmpagliflozin34$33,639
FarxigaDapagliflozin Propanediol23$22,614
TrulicityDulaglutide16$16,912
XareltoRivaroxaban11$14,685
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,950
Repatha SureclickEvolocumab11$10,487
JanumetSitagliptin Phos/Metformin Hcl15$7,306
Synjardy XrEmpagliflozin/Metformin Hcl12$6,563
Combivent RespimatIpratropium/Albuterol Sulfate13$6,346
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,901
SymbicortBudesonide/Formoterol Fumarate13$5,625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$96$85,73182 claims
Novo NordiskOzempic, Levemir$62$82,60278 claims
PfizerEliquis$18$63,71490 claims
Boehringer IngelheimJardiance, Synjardy Xr, Combivent Respimat$38$46,54859 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$76$40,18953 claims
GSKAnoro Ellipta$42$5,90112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,522 family providers in North Carolina.

Other family in Harmony

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →